Daré Bioscience, Inc.
DARE
$2.04
-$0.04-1.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -21.20K | 25.40K | -63.60K | 41.70K | 22.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.20K | 25.40K | -63.60K | 41.70K | 22.40K |
| Cost of Revenue | -- | 2.30M | 14.22M | 25.00K | -- |
| Gross Profit | -21.20K | -2.27M | -14.29M | 16.70K | 22.40K |
| SG&A Expenses | 2.38M | 2.31M | 2.00M | 2.04M | 2.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.81M | 4.61M | 5.32M | 4.72M | 7.38M |
| Operating Income | -3.83M | -4.58M | -5.39M | -4.68M | -7.36M |
| Income Before Tax | -4.02M | -4.38M | -5.51M | -4.70M | 12.91M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.02M | -4.38M | -5.51M | -4.70M | 12.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.02M | -4.38M | -5.51M | -4.70M | 12.91M |
| EBIT | -3.83M | -4.58M | -5.39M | -4.68M | -7.36M |
| EBITDA | -3.37M | -4.42M | -5.38M | -4.67M | -7.34M |
| EPS Basic | -0.45 | -0.50 | -0.69 | -0.55 | 1.53 |
| Normalized Basic EPS | -0.28 | -0.31 | -0.48 | -0.34 | 0.96 |
| EPS Diluted | -0.45 | -0.50 | -0.69 | -0.55 | 1.52 |
| Normalized Diluted EPS | -0.28 | -0.31 | -0.48 | -0.34 | 0.95 |
| Average Basic Shares Outstanding | 8.87M | 8.76M | 8.02M | 8.53M | 8.41M |
| Average Diluted Shares Outstanding | 8.87M | 8.76M | 8.02M | 8.53M | 8.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |